Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multimodal Neuroimaging in Parkinson's Disease
NCT02599753Phase 2Completed
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Aug 2015
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Florbenazine F-18 in Parkinson's disease (PD), sponsored by Chang Gung Memorial Hospital. Started Aug 2015; status: completed.
02
Drugs
Florbenazine F-18
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02599753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02599753.